L. Spilabotti

发表

Quantitation of tissue polypeptide antigen (TPA) in hepatic and systemic circulation in patients with chronic liver diseases

R. Guarisco, F. Paglia, C. Puoti, 2009, Journal of gastroenterology and hepatology.

Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis.

R. Guarisco, L. Durola, C. Puoti, 2007, Journal of gastrointestinal and liver diseases : JGLD.

Rapid virological response as a predictor of sustained response in HCV‐infected patients with persistently normal alanine aminotransferase levels: A multicenter study

G. Barbarini, R. Guarisco, A. Nicolini, 2011, Journal of viral hepatitis.

HCV carriers with normal alanine aminotransferase levels: healthy persons or severely ill patients? Dealing with an everyday clinical problem.

R. Guarisco, C. Puoti, L. Bellis, 2010, European journal of internal medicine.

Occurrence of hepatocellular carcinoma in an apparently 'healthy' HCV patient.

R. Guarisco, L. Durola, C. Puoti, 2005, European journal of gastroenterology & hepatology.

Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon α‐2a and ribavirin: a multicentric study

G. Barbarini, R. Villani, R. Guarisco, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Antiviral treatment of HCV carriers with persistently normal ALT levels.

R. Guarisco, C. Puoti, L. Bellis, 2008, Mini reviews in medicinal chemistry.

Diagnosis, management, and treatment of hepatitis C

R. Guarisco, C. Puoti, L. Bellis, 2009, Hepatology.

Should we treat HCV carriers with normal ALT levels? The ‘5Ws’ dilemma

R. Guarisco, C. Puoti, L. Bellis, 2012, Journal of viral hepatitis.